|
| |
Xenometrix Incorporated Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
BioPortfolio - Xenometrix Incorporated
Xenometrix Incorporated - Entry on Bioportfolio's Biocorporate Database.
http://www.bioportfolio.com/biocorporate/11091-Xenometrix_In...
|
Aurora Biosciences Licenses Xenometrix Gene Profiling Technology
BOULDER, Colo., June 4 /PRNewswire/ -- Aurora Biosciences Corporation (Nasdaq: ABSC) and Xenometrix, Inc. (OTC Bulletin Board: XENO), today announced that ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
MDS Pharma Services - Announcements
Before joining MDS Pharma Services, Dr. Gee was President and CEO of Xenometrix, Inc., a company that pioneered gene expression profiling to describe ...
http://www.mdsps.com/News/Announcements/2003/02-17-2003/Defa...
|
Xenometrix Grants Gene Expression Profiling Patent License to ...
Santa Fe Company Is The Third To Take A Non-Exclusive License BOULDER, Colo., July 30 /PRNewswire/ -- Xenometrix, Inc. (OTC Bulletin Board: XENO) today ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...
|
Endocrine Disruptor Screening and Testing Advisory Committee Final ...
OSI Pharmaceuticals, Inc., and that cross-licensed from Xenometrix, Inc., to deliver a technology. platform which we believe will be of great value to the ...
http://www.epa.gov/endo/pubs/edstac/app-iv14.pdf...
|
Volume 3, 2002, International Journal of Molecular Sciences
2Xenometrix Research Laboratory, Xenometrix Inc., Boulder, Colorado 80301, USA. Mercury Induces Cytotoxicity and Transcriptionally Activates Stress Genes in ...
http://www.hsc.wvu.edu/sop/compchem/mdpi/ijms/list02.htm...
|
Phil Hanawalt's CV
Scientific Advisory Board, Xenometrix, Inc., Boulder, Colorado, 1993-97. Chair, External Advisory Board, Environmental Health Sciences Ctr, Sealy Ctr for ...
http://www.stanford.edu/~hanawalt/cv.html...
|
Technology evaluation: SAGE, Genzyme Molecular Oncology John Bartlett
Xenometrix Inc: Xenometrix grants gene expression. profiling patent license to Genzyme Corp. Press release 16. February (1999). 317452. ...
http://www.biomedcentral.com/content/pdf/cd-398810.pdf...
|
The NAD+ precursors, nicotinic acid and nicotinamide protect cells ...
J Schneider and S Beard at Xenometrix, Inc. (Boulder, CO, USA) performed these assays. Briefly, HepG2 cells were transfected with the pSP-CAT plasmid by ...
http://www.nature.com/cdd/journal/v7/n3/full/4400658a.html...
|
In vitro carcinogenicity testing: Present and future perspectives ...
Xenometrix Inc, markets test. systems for various types of toxicological screening using an. engineered human hepatoma cell line [48] and several ...
http://www.biomedcentral.com/content/pdf/cd-395572.pdf...
|
|
